← Back to Patent Explorer
US4269819A Expired / Lapsed US ⏱️ 0.0 years remaining

2,4,6-Triiodobenzonitrile derivatives and X-ray contrast media comprising them

Assignee: Bayer Pharma AG
•
Filing: 1979-07-12
•
Granted: 1981-05-26
•
Expires: 1999-07-12
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 2,4,6-Triiodobenzonitriles of the formula <IMAGE> wherein Z is a direct bond or alkylene, X is -COOH or -NR1R2 wherein R1 is H or hydrocarbon or hydroxy-hydrocarbon and R2 is lower acyl, and Y is H or -COOH, and their simple esters, amides and pharmaceutically acceptable salts, are useful as X-ray contrast agents and can be prepared by diazotizing the corresponding 2,4,6-triiodoanilines followed by reaction with a metal cyanide.

Inventors

  • 👤 Heinz Gries

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 22:54
CPC Classifications
C; C07; C07C; C07C255/00; C07C255/49; C07C255/57

Claims Analysis

Total Claims: 21
Claim 1
Independent Claim 184 words
A compound of the formula ##STR6## wherein Z is a direct bond or alkylene or alkenylene of up to 7 carbon atoms; X is --COOH or ##STR7## wherein R 1 is a hydrogen atom or alkyl or hydroxy alkyl of up to 4 carbon atoms or a corresponding hydroxy alkyl group, and R 2 is the acyl radical of a hydrocarbon carboxylic acid of 2 to 5 carbon atoms or of a corresponding hydroxy carboxylic acid, and Y is a hydrogen atom or --COOH; and the physiologically acceptable salts with bases, and the corresponding esters and acid amides of the above compounds wherein at least one of X and Y is (a) of the formula --CO--OR wherein R is hydrocarbon of 1-4 carbon atoms or a corresponding hydrocarbon group substituted by one or more hydroxy groups, or (b) of the formula --CO--NR 3 --R 4 wherein R 3 and R 4 each is a hydrogen atom or alkyl of 1-4 carbon atoms or corresponding alkyl substituted by 1-3 hydroxy groups, or (c) of the formula --CO--NH--R 5 wherein R 5 is methyl or ethyl.
Claim 2
Dependent Claim 184 words
A compound of the formula ##STR6## wherein Z is a direct bond or alkylene or alkenylene of up to 7 carbon atoms; X is --COOH or ##STR7## wherein R 1 is a hydrogen atom or alkyl or hydroxy alkyl of up to 4 carbon atoms or a corresponding hydroxy alkyl group, and R 2 is the acyl radical of a hydrocarbon carboxylic acid of 2 to 5 carbon atoms or of a corresponding hydroxy carboxylic acid, and Y is a hydrogen atom or --COOH; and the physiologically acceptable salts with bases, and the corresponding esters and acid amides of the above compounds wherein at least one of X and Y is (a) of the formula --CO--OR wherein R is hydrocarbon of 1-4 carbon atoms or a corresponding hydrocarbon group substituted by one or more hydroxy groups, or (b) of the formula --CO--NR 3 --R 4 wherein R 3 and R 4 each is a hydrogen atom or alkyl of 1-4 carbon atoms or corresponding alkyl substituted by 1-3 hydroxy groups, or (c) of the formula --CO--NH--R 5 wherein R 5 is methyl or ethyl.
Claim 3
Dependent Claim 9 words
A compound of claim 1 wherein Y is H.
Claim 4
Dependent Claim 9 words
A compound of claim 1 wherein Y is --COOH.
Claim 5
Dependent Claim 12 words
A compound of claim 1 wherein wherein Z is a direct bond.
Claim 6
Dependent Claim 13 words
A compound of claim 4 wherein X is --NR 1 R 2 .
Claim 7
Dependent Claim 12 words
A compound of claim 5 wherein R 1 is a hydrogen atom.
Claim 8
Dependent Claim 15 words
A compound of claim 1 wherein Z is alkylene of up to 4 carbon atoms.
Claim 9
Dependent Claim 13 words
A compound of claim 7 wherein X is --NR 1 R 2 .
Claim 10
Dependent Claim 12 words
A compound of claim 8 wherein R 1 is a hydrogen atom.
Claim 11
Dependent Claim 7 words
5-Cyano-2,4,6-triiodoisophthalic acid, a compound of claim 1.
Claim 12
Dependent Claim 8 words
5-Cyano-2,4,6-triiodoisophthalic acid monomethylamide, a compound of claim 1.
Claim 13
Dependent Claim 8 words
5-Cyano-2,4,6-triiodoisophthalic acid bis(2-hydroxyethyl)amide, a compound of claim 1.
Claim 14
Dependent Claim 7 words
5-Cyano-2,4,6-triiodobenzoic acid, a compound of claim 1.
Claim 15
Dependent Claim 7 words
β-(2,4,6-Triiodo-3-cyanophenyl-)α-ethylpropionic acid, a compound of claim 1.
Claim 16
Dependent Claim 7 words
5-Cyano-3-acetylamino-2,4,6-triiodobenzoic acid, a compound of claim 1.
Claim 17
Dependent Claim 7 words
3-Cyano-5-acetylaminomethyl-2,4,6-triiodobenzoic acid, a compound of claim 1.
Claim 18
Dependent Claim 8 words
5-Cyano-2,4,6-triiodoisophthalic acid mono-N-(2-hydroxyethyl)amide, a compound of claim 1.
Claim 19
Dependent Claim 8 words
5-Cyano-2,4,6-triiodoisophthalic acid monoamide, a compound of claim 1.
Claim 20
Dependent Claim 30 words
An X-ray contrast agent adapted for oral or intravenous administration comprising a radiopaque amount per unit dosage of a compound of claim 1, in admixture with a pharmaceutically acceptable carrier.
Claim 21
Dependent Claim 27 words
A method for conducting a radiological examination of a patient which comprises administering systemically thereto prior to examination a radiopaque amount of a compound of claim 1.

References Cited (Backward Citations)

DE1467994A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-05-25 1984-11-24 1985-05-26 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-05-25 1988-11-24 1989-05-26 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-05-25 1992-11-24 1993-05-26 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag